id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-273828-557vlq9d	Brito, Carlos Antunes	Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm?	2020-08-27		.txt	text/plain	3095	166	50	Since the first reports of coronavirus disease 2019 (COVID-19) cases in December 2019 in China, numerous papers have been published describing a high frequency of liver injury associated with severe acute respiratory syndrome coronavirus 2 infection, many of them proposing a link between these findings and patient outcomes. Recently, many papers have been published reporting gastrointestinal manifestations, including acute liver injury, with increased levels of aminotransferases, in COVID-19 patients; these manifestations have been reported more frequently in patients with severe forms of this disease. Liver injury related to SARS-CoV-2 disease has been defined by increased liver enzyme serum levels, mainly aminotransferases and bilirubin, during the infection course in patients with or without previous liver disease [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Wide variability in deviations of liver enzyme serum levels from normal values is observed in infected patients, with an elevation frequency ranging from 16% to 62% for aminotransferases and from 5% to 21% for bilirubin.	./cache/cord-273828-557vlq9d.txt	./txt/cord-273828-557vlq9d.txt